Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology

  • Johnatas D. Silva
  • , Ligia L. De Castro
  • , Cassia L. Braga
  • , Gisele P. Oliveira
  • , Stefano A. Trivelin
  • , Carlos M. Barbosa-Junior
  • , Marcelo M. Morales
  • , Claudia C. Dos Santos
  • , Daniel J. Weiss
  • , Miquéias Lopes-Pacheco
  • , Fernanda F. Cruz
  • , Patricia R.M. Rocco*
  • *Autor correspondiente de este trabajo
  • Museu Nacional/UFRJ
  • National Institute of Science and Technology for Regenerative Medicine
  • University of Toronto
  • University of Vermont

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

53 Citas (Scopus)

Resumen

Although mesenchymal stromal cells (MSCs) have demonstrated beneficial effects on experimental acute respiratory distress syndrome (ARDS), preconditioning may be required to potentiate their therapeutic effects. Additionally, administration of cell-free products, such as extracellular vesicles (EVs) obtained from MSC-conditioned media, might be as effective as MSCs. In this study, we comparatively evaluated the effects of MSCs, preconditioned or not with serum collected from mice with pulmonary or extrapulmonary ARDS (ARDSp and ARDSexp, respectively), and the EVs derived from these cells on lung inflammation and remodeling in ARDSp and ARDSexp mice. Administration of MSCs (preconditioned or not), but not their EVs, reduced static lung elastance, interstitial edema, and collagen fiber content in both ARDSp and ARDSexp. Although MSCs and EVs reduced alveolar collapse and neutrophil cell counts in lung tissue, therapeutic responses were superior in mice receiving MSCs, regardless of preconditioning. Despite higher total cell, macrophage, and neutrophil counts in bronchoalveolar lavage fluid in ARDSp than ARDSexp, MSCs and EVs (preconditioned or not) led to a similar decrease. In ARDSp, both MSCs and EVs, regardless of preconditioning, reduced levels of tumor necrosis factor-(TNF-) α;, interleukin-6, keratinocyte chemoattractant (KC), vascular endothelial growth factor (VEGF), and transforming growth factor-(TGF-) β in lung homogenates. In ARDSexp, TNF-α, interleukin-6, and KC levels were reduced by MSCs and EVs, preconditioned or not; only MSCs reduced VEGF levels, while TGF-β levels were similarly increased in ARDSexp treated either with saline, MSCs, or EVs, regardless of preconditioning. In conclusion, MSCs yielded greater overall improvement in ARDS in comparison to EVs derived from the same number of cells and regardless of the preconditioning status. However, the effects of MSCs and EVs differed according to ARDS etiology.

Idioma originalInglés
Número de artículo8262849
PublicaciónStem Cells International
Volumen2019
DOI
EstadoPublicada - 2019
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology'. En conjunto forman una huella única.

Citar esto